<code id='28A9CEA45E'></code><style id='28A9CEA45E'></style>
    • <acronym id='28A9CEA45E'></acronym>
      <center id='28A9CEA45E'><center id='28A9CEA45E'><tfoot id='28A9CEA45E'></tfoot></center><abbr id='28A9CEA45E'><dir id='28A9CEA45E'><tfoot id='28A9CEA45E'></tfoot><noframes id='28A9CEA45E'>

    • <optgroup id='28A9CEA45E'><strike id='28A9CEA45E'><sup id='28A9CEA45E'></sup></strike><code id='28A9CEA45E'></code></optgroup>
        1. <b id='28A9CEA45E'><label id='28A9CEA45E'><select id='28A9CEA45E'><dt id='28A9CEA45E'><span id='28A9CEA45E'></span></dt></select></label></b><u id='28A9CEA45E'></u>
          <i id='28A9CEA45E'><strike id='28A9CEA45E'><tt id='28A9CEA45E'><pre id='28A9CEA45E'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:3
          Red Blood Cells
          Adobe

          The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

          The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

          advertisement

          Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Advocates call out 'SNL' over stereotypes, errors in sickle cell skit
          Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

          CraigF.Walker/TheBostonGlobeMaryBrownwassippingcoffeeathomeinOntario,Calif.,Sundaymorningwhenafriend

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          CRISPR gene editing developments we’re watching in 2024

          ChristineKao/STATLifeintheCRISPRlanetendstomoveatlightningspeed.Thisyearsawthefirst-everapprovalofam